Lymphoma Drug Undergoing Trial Makes MS Relapses 5 Times Less Likely

Off Health, Health Information, Human Health, Life Sciences, Medical Daily, Medicine, Natural Health News, Science and Health, Science and Research

A lymphoma drug undergoing a phase 3 clinical trial hopes to make multiple sclerosis relapses five times less likely.
Read Original Article: Lymphoma Drug Undergoing Trial Makes MS Relapses 5 Times Less Likely »

About The Author